Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Tesla Bulls vs. Bears Are Getting Loud Ahead of Earnings

Tesla heads into earnings with its uptrend intact but sentiment widely divided, as investors weigh future upside against real valuation concerns.

MarketBeat

Defense Spending Is Rising—Here Are 3 Stocks Built for Turbulent Times

With geopolitcal tensions rising and world governments increasing defense spending, aerospace stocks are poised to benefit. We like these 3 large caps best.

MarketBeat

3M Earnings: Fundamentals and Capital Returns to Drive Highs in 2026

3M's capital return is safe and reliable for 2026, on track for modest distribution increases and semi-aggressive share count reduction.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Ways to Trade Amazon Ahead of Earnings

Amazon heads into February's earnings range-bound and seemingly asleep, forcing investors to choose between betting on a catch-up play or waiting for clarity.

MarketBeat

Sea, Space, & Sky: 3 Frontier Robotics Stocks Under $20

Frontier robotics stocks are capturing investor attention as they transition from research concepts to essential infrastructure for space and defense economies.

MarketBeat

Rocket Lab Gets a Big Upgrade: Will Upside Follow?

Morgan Stanley just turned bullish on Rocket Lab, upgrading the stock to Overweight from Equalweight and raising its price target to a Street-high $105.

MarketBeat

Moderna Pops 17%—Is There Life in MRNA, Down 90% from COVID High?

COVID-19 vaccine stock Moderna just got its biggest lift in recent memory, moving up 17%. Can MRNA stage a broader recovery, down +90% from its all-time high?

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

AMD Rebound Begins: It’s Not Too Late to Get In

Advanced Micro Devices' rebound is underway and about to gain momentum as outperformance, guidance, and the expected launch of MI450 GPUs drive sentiment.

MarketBeat

Utility Gas Inflation Is Soaring. This Stock Is a Clear Winner

Utility gas prices are surging as demand outpaces supply. Shareholders of the largest natural gas-only utility company in the U.S. should continue to benefit.

MarketBeat

Unity Software Is Falling—So Why Are Pros Getting More Bullish?

Institutional investors are upgrading Unity Software as the company executes its turnaround strategy and launches new artificial intelligence advertising tools.

MarketBeat

AI Needs Power Now—Bloom Energy and American Electric Power Deliver

Artificial intelligence data center demand is driving massive commercial contracts for fuel cell technology as utilities race to solve power shortages.

MarketBeat

2 Healthcare Names That Could Get a Big Boost From Earnings

Both Abbott Laboratories and Intuitive Surgical report fourth-quarter results in late January—and both companies offer investors multiple reasons to be bullish.

MarketBeat

3 Key Ways D-Wave Is Developing an Advantage in Quantum Computing

D-Wave's recent acquisition announcement and a major technological breakthrough with implications for scalability help to set it apart amid setbacks for rivals.

MarketBeat

Short Squeeze Season: Is Super Micro Ready to Fly?

A surge in Super Micro Computer stock highlights a potential turnaround as Taiwan Semiconductor confirms insatiable demand for artificial intelligence.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026

These three biotech stocks combine scale, late-stage pipelines, and analyst confidence, giving investors compelling upside potential in 2026

MarketBeat

2 Analysts Sour On Super Micro: Can SMCI Recover Amid +40% Fall?

Analysts see Super Micro as in a bit of a pickle. See how the company's trade-off between growth and profitability is shifting sentiment around the stock.

MarketBeat

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All

As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit from the industry’s next leg up.

MarketBeat

3 Data Center Beneficiaries Raising Dividends Up to 60%

Demand from data center build-outs contributed to impressive gains for three stocks in 2025, and now, higher dividends in 2026.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Insiders Are Selling These 3 High-Flying Stocks

MP Materials, Oklo, and Redwire are seeing enormous insider selling over the last 1-2 months. See what these sales mean for each name.

MarketBeat

High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026

2026 could be a pivotal year for three biotech names, including a standout in the hemodialysis space and two emerging companies with strong pipelines.

MarketBeat

3 “Forever Stocks” to Hold When the Market Won’t Sit Still

Chevron, Colgate-Palmolive, and Merck highlight how dividends, durable businesses, and long-term growth drivers can support a buy-and-hold investment strategy

MarketBeat

3 Innovative Crypto ETFs That May Surprise in 2026

With new approaches to crypto, these ETFs offer benefits including staking, regular distributions, and a focus on lesser-known but important digital assets.

MarketBeat

2 Buffett Stocks to Load Up On—And 1 to Ditch

With Buffett having officially stepped down at Berkshire Hathaway, investors might continue to follow his lead when it comes to these popular names.

MarketBeat

Can't Choose Between Silver and Gold? These ETFs Hold Both

Silver and gold broke out over the past year, but analysts believe it’s just the beginning of a bull cycle. These ETFs provide exposure to both precious metals.

MarketBeat

Big Risk, Potentially Bigger Return For These 3 Leveraged ETF's

Three leveraged ETFs—two focused on commodities and a third on FANG+ stocks—may appeal to investors willing to take a risk for outsized returns.

1 … 103 104 105 106

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.